Summary
Kynurenine, tryptophan and 5-hydroxyindoleacetic acid were measured in human lumbar and cisternal cerebrospinal fluid (CSF) taken during pneumoencephalography. The results do not support the hypothesis that any substantial part of the CSF kynurenine is of central origin. However, the results suggest that CSF kynurenine is reduced in some epileptic subjects and this seems to be due to the disease rather than anticonvulsants. This finding is of interest in view of the reported convulsant effect of kynurenine in experimental animals.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anderson, G. M., Purdy, W. C. A liquid chromatographic-fluorometric system for the analysis of indoles in physiological samples. Anal. Chem.51, 283–286 (1979).
Gál, E. M. Cerebral tryptophan-2.3-dioxygenase (pyrrolase) and its induction in rat brain. J. Neurochem.22, 861–863 (1974).
Gál, E. M., Sherman, A. D. Synthesis and metabolism of L-kynurenine in rat brain. J. Neurochem.30, 607–613 (1978).
Gál, E. M., Sherman, A. D. L-Kynurenine: its synthesis and possible regulatory function in brain. Neurochem. Res.5, 223–239 (1980).
Garelis, E., Young, S. N., Lal, S., Sourkes, T. L. Monoamine metabolites in CSF: their sites of origin in relation to clinical studies. Brain Res.79, 1–8 (1974).
Green, A. R., Curzon, G. The effect of tryptophan metabolites on brain 5-hydroxytryptamine metabolism. Biochem. Pharmacol.19, 2061–2068 (1970).
Hagberg, B., Hamfet, A., Hansson, O. Tryptophan load tests and pyridoxal-5-phosphate levels in epileptic children: cryptogenic epilepsy. Acta Paediat. Scand.55, 371–384 (1966).
Hughes, P. A. M., Bower, B. D., Raine, D. N., Syed, N. Metabolism of tryptophan in childhood epilepsy. Arch. Dis. Childhood41, 642–651 (1966).
Jakupčevic, M., Lackovic, Z., Stefoski, D., Bulat, M. Nonhomogeneous distribution of 5-hydroxyindoleacetic acid and homovanillic acid in the lumbar cerebrospinal fluid of man. J. Neurol. Sci.31, 165–171 (1977).
Joseph, M. H. The determination of kynurenine: a single gas-liquid Chromatographic method applicable to urine, plasma, brain and CSF. J. Chromatog.146, 33–41 (1978).
Joseph, M. H., Kadam, B. V. Kynurenine: penetration to the brain, effect on brain tryptophan and 5-hydroxytryptamine metabolism and binding to plasma albumin. Brit. J. Pharmacol.66, 483P-484P (1979).
Joseph, M. H., Baker, H. F., Lawson, A. M. Positive identification of kynurenine in rat and human brain. Biochem. Soc. Trans.6, 123–126 (1978).
Joseph, M. H., Baker, H. F., Crow, T. J., Riley, G. J., Risby, D. Brain tryptophan metabolism in schizophrenia: a post mortem study of metabolites on the serotonin and kynurenine pathways in schizophrenic and control subjects. Psychopharmacol.62, 279–285 (1979).
Lapin, I. P. Interaction of kynurenine and its metabolites with tryptophan, serotonin and its precursors and oxotremorine. Psychopharmacol.26, 237–247 (1972).
Lapin, I. P. Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice. J. Neural Transm.42, 37–43 (1978).
Lapin, I. P. Experimental studies on kynurenines as neuroactive tryptophan metabolites: past, present and future. Trends Pharm. Sci.1, 410–412 (1980).
Lapin, I. P., Prakhic, I. B., Kiseleva, I. P. Excitatory effects of kynurenine and its metabolites, amino acids and convulsants administered into brain ventricles: differences between rats and mice. J. Neural Transm.54, 229–238 (1982).
Oldendorf, W. H., Szabo, J. Amino acid assignment to one of three blood-brain barrier amino acid carriers. Amer. J. Physiol.230, 94–98 (1976).
Perkins, M. N., Stone, T. W. An iontophoretic investigation of the actions of convulsant kynurenines and their interactions with the endogenous excitant, quinolinic acid. Brain Res.247, 184–187 (1982).
Perry, T. L., Hansen, S., Kennedy, J. CSF amino acids and plasma-CSF amino acid ratios in adults. J. Neurochem.24, 587–589 (1975).
Riederer, P., Kleinberger, G., Jellinger, K. L-Valine: mechanism of action on human hepatic encephalopathy. In: Aminosäuren und Ammoniakstoffwechsel bei Leberinsuffizienz (Holm, E., ed.), pp. 117–124. Baden-Baden: Witzstrock. 1982.
Sternberg, E. M., Van Woert, M. H., Young, S. N., Magnussen, I., Baker, H., Gauthier, S., Osterland, C. K. Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa. New Eng. J. Med.303, 782–787 (1980).
Stone, T. W., Perkins, M. N. Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS. Eur. J. Pharmacol.72, 411–412 (1981).
Wolf, H. Studies on tryptophan metabolism in man. Scand. J. Clin. Lab. Invest. (Suppl.)136, 1–186 (1974).
Yoshida, R., Hayaishi, O. Induction of pulmonary indoleamine-2.3-dioxygenase by intraperitoneal injection of bacterial lipopolysaccharide. Proc. Natl. Acad. Sci. USA75, 3998–4000 (1978).
Young, S. N., Lal, S., Sourkes, T. L., Feldmuller, F., Aronoff, A., Martin, J. B. Relationship between tryptophan in serum and CSF, and 5-hydroxyindoleacetic acid in CSF of man: effect of cirrhosis of liver and probenecid administration. J. Neurol. Neurosurg. Psychiatry38, 322–330 (1975).
Young, S. N., Gauthier, S., Anderson, G. M., Purdy, W. C. Tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human cerebrospinal fluid: interrelationship and the influence of age, sex, epilepsy and anticonvulsant drugs. J. Neurol. Neurosurg. Psychiatry43, 438–445 (1980).
Yuwiler, A., Oldendorf, W. H., Geller, E., Braun, L. Effect of albumin binding and amino acid competition on tryptophan uptake into brain. J. Neurochem.28, 1015–1023 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Young, S.N., Joseph, M.H. & Gauthier, S. Studies on kynurenine in human cerebrospinal fluid: Lowered levels in epilepsy. J. Neural Transmission 58, 193–204 (1983). https://doi.org/10.1007/BF01252805
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01252805